Default company panoramic image


Based on Research made in Belgian Universities & patents filed -obtained, OnCoBel will select anticancer compounds to enter into Phase I/II

  • Stage Product In Development
  • Industry Biotechnology
  • Location Genappe, Walloon Region, Belgium
  • Currency EUR
  • Founded April 2008
  • Employees 0
  • Website

Company Summary

OnCoBel has currently a pipeline of 6 NCE's. Drug discovery is supported by in-licenses. The promising novel drug candidates are now at stages of in vitro/in vivo validation, obtained by computerized quantitative video microscopy and in mice orthotopic models, thus ready to complete the Regulatory (and non Regs) pre-clinical phases for the filing of IND-IMPD dossiers for PhI/ II trials, offering a competitive end of Phase I out-licensing process.


  • Default avatar
    Michel Albert DELEERS
    CEO - Administrateur Délégué

    A start of career with research in Biochemistry & Biophysics, then in Cancer & Endocrinology at University from '74 to '83 has led me to a research position for 7 further years at UCB. After this research period, first as Manager, then as VP of Global Pharma & Analytical Developments, I have developed Zyrtec products in Europe and represented UCB to develop Zyrtec & Keppra products in USA & Japan, & 22 patents. Since 2010 I am developing OnCoBel

  • Default avatar
    Didier SERTEYN
    CSO - Member of Board

    Didier Serteyn graduated in veterinary medicine at the University of Liège in 1982. His second thesis presented in 1989, focuses on the post-anesthetic myopathy equine. He is now professor of surgery and anesthesia of large animals, Chairman of the Department of Clinical Sciences pets and horses. He conducts research in the European Research Centre Horse Mont-le-Soie center funded by the Walloon Region and the Ministry of Agriculture. Since 2007,

  • Default avatar
    Robert BINAME
    President of Board

    A diversified career within the Pharmaceutical industry allowed me to acquire a sound experience in the following fields: Project & Program management, Outsourcing management, Operational Strategy, Contracts negotiations, Supply chain management, IT projects development, International projects coordination, Due diligences, Assessment of industrial rationalization scenarios, Business analysis. Dr Binamé is also an expert in Change Management


  • Default avatar
    nobody currently
    Default avatar
    Mr Serge Bultot, réviseur d entreprise à Dinant

Previous Investors

  • Default avatar
    Founders of the s.a.